Spectral MD Holdings Ltd
LSE:SMD

Watchlist Manager
Spectral MD Holdings Ltd Logo
Spectral MD Holdings Ltd
LSE:SMD
Watchlist
Price: 58 GBX 10.48%
Market Cap: £79.7m

Spectral MD Holdings Ltd
Investor Relations

Spectral MD Holdings Ltd. develops proprietary AI algorithms and optical technology to help clinicians to make faster treatment decisions in wound care sector. The company is headquartered in Dallas, Texas. The company went IPO on 2021-06-22. The firm is focused on developing DeepView wound imaging system. The firm is also providing contract development and research services to the governmental agencies. The firm is offerings its services to the Biomedical Advanced Research and Development Authority (BARDA).

Show more
Loading
SMD
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2023
Call Date
Nov 14, 2023
Q3 2023 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls
2023

Management

Mr. Wensheng Fan
Co-Founder, CEO & Exec. Director
No Bio Available
Mr. Nils Windler
Chief Financial Officer
No Bio Available
Dr. Niko Pagoulatos Ph.D.
Chief Operating Officer
No Bio Available
Dr. Jeffrey Thatcher Ph.D.
Chief Scientist
No Bio Available
Mr. Vincent S. Capone
Gen. Counsel & Corp. Sec.
No Bio Available
Ms. Christine Marks
VP of Marketing & Commercialization
No Bio Available
Dr. So-Jin Holohan Ph.D.
Head of UK/EU Clinical Research
No Bio Available
Dr. Jeffrey Carter M.D.
Chief Medical Consultant
No Bio Available
David Bronson
Financial Controller
No Bio Available

Contacts

Address
TEXAS
Dallas
2515 McKinney Ave.,, Suite 1000,
Contacts